1. Biology of Blood and Marrow Transplantation
Calcineurin and m-TOR Inhibitor-Free Post-Transplant Cyclophosphamide (PTC) and Bortezomib (B) Combination for the Prevention of Graft-Versus-Host Disease (GvHD): Phase I-II Study 
A. Samer Al-Homsi, MD, Kelli Cole, RN, MSN, Marlee Muilenburg, RN, BSN, Ulrich Duffner, MD, Muneer H. Abidi, MD, Stephanie F. Williams, MD, Aly A. Mageed, MD 
Biology of Blood and Marrow Transplantation 
Volume 22, Issue 3, (March 2016)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Immune reconstitution data: Upper graph-cumulative: mean and standard error of the mean represented. Lower graph - patients receiving no further immune suppressive (IS) therapy (n=8) and receiving systemic steroids (n=6).
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions

3. Figure 2
Biology of Blood and Marrow Transplantation  , DOI: ( /j.bbmt )
Copyright © Terms and Conditions